|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1991-7-11
|
|
pubmed:abstractText |
Ten patients with moderate or severe bacterial pneumonia with underlying diseases or complications were treated with cefuzonam (CZON) at a daily dose of 2 g to 4 g. The clinical effectiveness was good in 9 patients. No side effects or abnormal laboratory test results were observed in any patient. These results suggest that CZON may be useful in the treatment of bacterial pneumonia.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0368-2781
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
111-6
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
pubmed-meshheading:2041152-Aged,
pubmed-meshheading:2041152-Aged, 80 and over,
pubmed-meshheading:2041152-Bacterial Infections,
pubmed-meshheading:2041152-Ceftizoxime,
pubmed-meshheading:2041152-Drug Evaluation,
pubmed-meshheading:2041152-Female,
pubmed-meshheading:2041152-Humans,
pubmed-meshheading:2041152-Male,
pubmed-meshheading:2041152-Middle Aged,
pubmed-meshheading:2041152-Pneumonia
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
[Clinical evaluation of cefuzonam for bacterial pneumonia].
|
|
pubmed:affiliation |
Second Department of Internal Medicine, Nara Medical University.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
